# Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability

> **NCT05744479** · PHASE4 · RECRUITING · sponsor: **Centre for Addiction and Mental Health** · enrollment: 100 (estimated)

## Conditions studied

- Intellectual Disability
- Developmental Disability
- Obesity

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo
- **BEHAVIORAL:** Lifestyle Intervention

## Key facts

- **NCT ID:** NCT05744479
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-28
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05744479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05744479, "Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05744479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*